ephedrine hydrochloride 30mg tablets
de pharmaceuticals - ephedrine hydrochloride - oral tablet - 30mg
brompheniramine maleate, pseudoephedrine hydrochloride, syrup
mckesson corporation dba sky packaging - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. hypersensitivity to any of the ingredients. do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. do not use dextromethorphan in patients receiving monoamine oxidase (maoi) inhibitors (see precautions - drug interactions). antihistamines should not be used to treat lower respiratory tract conditions including asthma.
brompheniramine maleate, pseudoephedrine hydrochloride, dextromethorphan hydrobromide- brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup
preferred pharmaceuticals inc. - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. hypersensitivity to any of the ingredients. do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. do not use dextromethorphan in patients receiving monoamine oxidase inhibitors (maois) (see drug interactions ). antihistamines should not be used to treat lower respiratory tract conditions including asthma.
lidocaine hydrochloride- lidocaine hydrochloride solution
wockhardt usa llc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride topical solution is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type, or to other components of lidocaine hydrochloride topical solution.
ephedrine hydrochloride 30mg in 1ml solution for injection
martindale pharmaceuticals ltd - ephedrine hydrochloride - solution for injection - 30 milligram(s)/millilitre - ephedrine
ephedrine aguettant 30mg/ml, solution for injection
laboratoire aguettant 1 rue alexander fleming, 69007 lyon, france - ephedrine hydrochloride - solution for injection - ephedrine hydrochloride 30 mg/ml - cardiac therapy
paralief sinus tablets paracetamol 500 mg pseudoephedrine hydrochloride 30 mg
chanelle medical - pseudoephedrine hydrochloride; paracetamol - tablet - 500/30 milligram(s) - anilides; paracetamol; sympathomimetics; pseudoephedrine
ephedrin sintetica 50 mgml
cts ltd - ephedrine hydrochloride - solution for injection - ephedrine hydrochloride 50 mg/ml - ephedrine - ephedrine hydrochloride is used in the prevention and treatment of hypotension from spinal or epidural anaesthesia and during general anaesthesia, with or without a reduction in the heart rate, administered for a surgical or obstetric procedure.
hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride- hydrocodone bitartrate, chlorpheniramine mal
paddock laboratories, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is indicated for the temporary relief of cough and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is contraindicated for: hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is also contraindicated in patients with: risk summary hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.13), clinical considerations ]. there are no available data with hydrocodone bitartrate, chlorpheniramine maleate and pseudo
proin 50- phenylpropanolamine hydrochloride tablet, chewable
pegasus laboratories, inc. - phenylpropanolamine hydrochloride (unii: 8d5i63ue1q) (phenylpropanolamine - unii:33ru150wun) - phenylpropanolamine hydrochloride 50 mg - proin (phenylpropanolamine hydrochloride) is a sympathomimetic amine closely related to ephedrine. phenylpropanolamine hydrochloride (ppa) is the nonproprietary designtion for benzenemethanol,α - (1-aminoethyl) - hydrochloride, (r*,s*) -, (±). the empirical formula is c9h13no•hcl and the molecular weight is 187.67. it is a white crystalline compound having a slight aromatic odor. ppa is freely soluable in water and alcohol but is practically insoluable in ether, benzene and chloroform. the chemical structure of phenylpropanolamine hydrochloride is: